Contra-IL 2 activity of a lymphokine produced by a hybrid cell line of ALS-induced suppressor T cells.
Maki
T
T
Department of Surgery and Pathology, New England Deaconess Hospital, Boston, MA 02215.
Satomi
S
S
Gotoh
M
M
Monaco
A P
AP
D000818:Animals; D000961:Antilymphocyte Serum / Q000276:immunology*; D002460:Cell Line; D002850:Chromatography, Gel; D002852:Chromatography, Ion Exchange; D006085:Graft Survival / Q000276:immunology*; D006825:Hybridomas / Q000276:immunology; D007376:Interleukin-2 / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D016381:Islets of Langerhans Transplantation; D008222:Lymphokines / Q000096:biosynthesis* / Q000302:isolation & purification; D051379:Mice; D008809:Mice, Inbred C3H; D013602:T-Lymphocytes, Cytotoxic / Q000187:drug effects / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology*; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D007376:Interleukin-2; D008222:Lymphokines